| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers S > Headlines for Stiefel Laboratories, Inc. > News item |
SAC Capital buys 2 million shares of Barrier Therapeutics
By Lisa Kerner
Charlotte, N.C., July 2 - Investors led by SAC Capital Advisors, LLC bought 2,097,290 shares of Barrier Therapeutics, Inc. for an 8% stake in the company.
The shares were purchased between May 1 and July 1 priced from $1.89 to $4.05 each, it was reported in a schedule 13D filed with the Securities and Exchange Commission.
SAC Capital beneficially owns 2,820,200 shares of the Princeton, N.J.-based pharmaceutical company.
In June, Stiefel Laboratories, Inc., a Coral Gables, Fla., independent pharmaceutical company, announced it would acquire Barrier for $4.15 per share, or approximately $148 million.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.